CVS unveils AI platform raises 2025 forecast, projecting $400B revenue and improved earnings to enhance consumer healthcare experience.
The healthcare giant expects its turnaround efforts to pay off as it raised its full-year outlook and expects that momentum ...
CVS Health shares climbed Tuesday after the health conglomerate raised its full-year outlook and outlined plans for a new AI ...
CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer recently commented on. Cramer praised the company’s CEO during the episode, as he commented: “This stock has become the best performer ...
How CVS’s new engagement app is trying to change American healthcare - The pharmacy and drugstore chain plans to launch the ...
Dec 9 (Reuters) - CVS Health on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, ...
CVS Caremark settles pharmacy underpayment allegations for $5M, reimbursing Oklahoma pharmacies for 68,099 prescriptions filled from 2024 to 2025.
In addition to the updates for 2025, CVS offered its first look at expected earnings for 2026. The company said it ...
CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...
CVS Health used its Investor Day on Tuesday as a megaphone for the retailer’s success, raising its full-year financial ...
It’s part of a larger battle between Louisiana officials and big health care companies over prescription drug prices.
CVS Health’s Aetna health insurance unit said it will “integrate pharmacy prescriptions and medical procedures into a single ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results